130 related articles for article (PubMed ID: 33759643)
1. Role of the ratio of NSE serum concentration in evaluating the therapeutic effect on metastatic neuroendocrine neoplasms of the liver.
Kan J; Tian Y; Shao Y; Xu H; Li X; Tang Q
Tumori; 2022 Apr; 108(2):157-164. PubMed ID: 33759643
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment Levels of Chromogranin A and Neuron-specific Enolase in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia.
Kečkéš Š; Palaj J; Waczulíková I; Dyttert D; Mojtová E; Kováč G; Durdík Š
In Vivo; 2021; 35(5):2863-2868. PubMed ID: 34410979
[TBL] [Abstract][Full Text] [Related]
3. Determination of neuron-specific enolase in patients with midgut-type tumour treated with somatostatin analogues.
Gut P; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Maciejewski A; Komarnicki P; Ruchała M
Endokrynol Pol; 2021; 72(4):308-318. PubMed ID: 34292567
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer.
Yan P; Han Y; Tong A; Liu J; Wang X; Liu C
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286335
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin-A as a serum marker for neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings.
Giovanella L; La Rosa S; Ceriani L; Uccella S; Erba P; Garancini S
Int J Biol Markers; 1999; 14(3):160-6. PubMed ID: 10569138
[TBL] [Abstract][Full Text] [Related]
6. The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer.
Wang CF; Peng SJ; Liu RQ; Yu YJ; Ge QM; Liang RB; Li QY; Li B; Shao Y
Dis Markers; 2020; 2020():8850873. PubMed ID: 33376560
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
Simpson S; Vinik AI; Marangos PJ; Lloyd RV
Cancer; 1984 Oct; 54(7):1364-9. PubMed ID: 6088026
[TBL] [Abstract][Full Text] [Related]
8. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
van de Pol M; Twijnstra A; ten Velde GP; Menheere PP
J Neurooncol; 1994; 19(2):149-54. PubMed ID: 7964990
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage.
Prados MC; Alvarez-Sala R; Blasco R; Chivato T; García Satué JL; García Río FJ; Gómez de Terrero FJ; Villamor J
Cancer; 1994 Sep; 74(5):1552-5. PubMed ID: 8062188
[TBL] [Abstract][Full Text] [Related]
11. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Pujol JL; Boher JM; Grenier J; Quantin X
Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401
[TBL] [Abstract][Full Text] [Related]
12. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Mjønes P; Sagatun L; Nordrum IS; Waldum HL
J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
[TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
14. Clinical biochemistry of neuron specific enolase.
Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
[TBL] [Abstract][Full Text] [Related]
15. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
[TBL] [Abstract][Full Text] [Related]
18. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
[TBL] [Abstract][Full Text] [Related]
19. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
20. Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines.
Påhlman S; Esscher T; Nilsson K
Lab Invest; 1986 May; 54(5):554-60. PubMed ID: 3009968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
